References
- Conn JW. Hypertension, the potassium ion and impaired carbohydrate tolerance. N Engl J Med 1965;273:1135–1143.
- Report of the expert committee on the diagnosis and classification of diabetes mellitus. Expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003;26 Suppl 1:S5–20.
- Page R, Boolell M, Kalfas A, et al. Insulin secretion, insulin sensitivity and glucose-mediated glucose disposal in Cushing’s disease: a minimal model analysis. Clin Endocrinol (Oxf) 1991;35:509–517.
- Melmed S, Ho K, Klibanski A, Reichlin S, Thorner M. Clinical review 75: Recent advances in pathogenesis, diagnosis, and management of acromegaly. J Clin Endocrinol Metab 1995;80:3395–3402.
- Fardella CE, Mosso L, Gomez-Sanchez C, et al. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. J Clin Endocrinol Metab 2000;85:1863–1867.
- Shimamoto K, Shiiki M, Ise T, et al. Does insulin resistance participate in an impaired glucose tolerance in primary aldosteronism? J Hum Hypertens 1994;8:755–759.
- Ishimori M, Takeda N, Okumura S, et al. Increased insulin sensitivity in patients with aldosterone producing adenoma. Clin Endocrinol (Oxf) 1994;41:433–438.
- Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–419.
- Borai A, Livingstone C, Kaddam I, Ferns G. Selection of the appropriate method for the assessment of insulin resistance. BMC Med Res Methodol 2011;11:158–167.
- Mitsui R, Fukushima M, Nishi Y, et al. Factors responsible for deteriorating glucose tolerance in newly diagnosed type 2 diabetes in Japanese men. Metabolism 2006;55:53–58.
- Chen H, Sullivan G, Yue LQ, et al. QUICKI is a useful index of insulin sensitivity in subjects with hypertension. Am J Physiol Endocrinol Metab 2003;284:E804–812.
- Catena C, Lapenna R, Baroselli S, et al. Insulin sensitivity in patients with primary aldosteronism: a follow-up study. J Clin Endocrinol Metab 2006;91:3457–3463.
- Gutch M, Kumar S, Razi SM, et al. Assessment of insulin sensitivity/resistance. Indian J Endocrinol Metab 2015;19:160–164.
- Sung KC, Reaven GM, Kim SH. Utility of homeostasis model assessment of beta-cell function in predicting diabetes in 12,924 healthy Koreans. Diabetes Care 2010;33:200–202.
- Malin SK, Finnegan S, Fealy CE, et al. β-Cell dysfunction is associated with metabolic syndrome severity in adults. Metab Syndr Relat Disord 2014;12:79–85.
- Luther JM. Effects of aldosterone on insulin sensitivity and secretion. Steroids 2014;91:54–60.
- Fallo F, Pilon C, Urbanet R. Primary aldosteronism and metabolic syndrome. Horm Metab Res 2012;44:208–214.
- J Widimský Jr, Sindelka G, Haas T, et al. Impaired insulin action in primary hyperaldosteronism. Physiol Res 2000;49:241–244.
- Reungjui S, Roncal CA, Mu W, et al. Thiazide diuretics exacerbate fructose-induced metabolic syndrome. J Am Soc Nephrol 2007;18:2724–2731.
- Fischer E, Adolf C, Pallauf A, et al. Aldosterone excess impairs first phase insulin secretion in primary aldosteronism. J Clin Endocrinol Metab 2013;98:2513–2520.
- Mosso LM, Carvajal CA, Maiz A, et al. J Hypertens. A possible association between primary aldosteronism and a lower beta-cell function. J Hypertens 2007;25:2125–2130.